ReP USP - Resultado da busca

Artigo de periodico
Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect (2017)
Aliberti, Ana Luisa Murbach; Queiroz, Alemer Cortat de; Praça, Fabíola Silva Garcia; Eloy, Josimar O.; Bentley, Maria Vitória Lopes Badra; Medina, Wanessa Silva Garcia
Fonte: AAPS PharmSciTech. Unidade: FCFRP
Assuntos: EMULSÕES (FORMAS FARMACÊUTICAS), ANTI-INFLAMATÓRIOS, PELE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALIBERTI, Ana Luisa Murbach et al. Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect. AAPS PharmSciTech, v. 18, n. 7, p. 2783-2791, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12249-017-0749-6. Acesso em: 23 out. 2025.
APA
Aliberti, A. L. M., Queiroz, A. C. de, Praça, F. S. G., Eloy, J. O., Bentley, M. V. L. B., & Medina, W. S. G. (2017). Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect. AAPS PharmSciTech, 18( 7), 2783-2791. doi:10.1208/s12249-017-0749-6
NLM
Aliberti ALM, Queiroz AC de, Praça FSG, Eloy JO, Bentley MVLB, Medina WSG. Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect [Internet]. AAPS PharmSciTech. 2017 ; 18( 7): 2783-2791.[citado 2025 out. 23 ] Available from: https://doi.org/10.1208/s12249-017-0749-6
Vancouver
Aliberti ALM, Queiroz AC de, Praça FSG, Eloy JO, Bentley MVLB, Medina WSG. Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect [Internet]. AAPS PharmSciTech. 2017 ; 18( 7): 2783-2791.[citado 2025 out. 23 ] Available from: https://doi.org/10.1208/s12249-017-0749-6
Artigo de periodico
Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection (2017)
Abriata, Juliana Palma; Eloy, Josimar O.; Riul, Thalita Bachelli; Campos, Patricia Mazureki; Baruffi, Marcelo Dias; Marchetti, Juliana Maldonado
Fonte: Materials Science and Engineering: C. Unidade: FCFRP
Assuntos: NANOPARTÍCULAS, TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, BIODISPONIBILIDADE, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABRIATA, Juliana Palma et al. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection. Materials Science and Engineering: C, v. 77, p. 1196-1203, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2017.03.266. Acesso em: 23 out. 2025.
APA
Abriata, J. P., Eloy, J. O., Riul, T. B., Campos, P. M., Baruffi, M. D., & Marchetti, J. M. (2017). Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection. Materials Science and Engineering: C, 77, 1196-1203. doi:10.1016/j.msec.2017.03.266
NLM
Abriata JP, Eloy JO, Riul TB, Campos PM, Baruffi MD, Marchetti JM. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection [Internet]. Materials Science and Engineering: C. 2017 ; 77 1196-1203.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.msec.2017.03.266
Vancouver
Abriata JP, Eloy JO, Riul TB, Campos PM, Baruffi MD, Marchetti JM. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection [Internet]. Materials Science and Engineering: C. 2017 ; 77 1196-1203.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.msec.2017.03.266
Artigo de periodico
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy (2017)
Eloy, Josimar O.; Petrilli, Raquel; Chesca, Deise Lúcia; Saggioro, Fabiano Pinto; Lee, Robert J.; Marchetti, Juliana Maldonado
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FMRP, SVOI, FCFRP
Assuntos: ANTICORPOS MONOCLONAIS, NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 115, p. 159-167, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.02.020. Acesso em: 23 out. 2025.
APA
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017). Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 115, 159-167. doi:10.1016/j.ejpb.2017.02.020
NLM
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Vancouver
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Artigo de periodico
Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells (2017)
Eloy, Josimar O.; Petrilli, Raquel; Brueggemeier, Robert W.; Marchetti, Juliana Maldonado; Lee, Robert J.
Fonte: Anti-Cancer Agents in Medicinal Chemistry. Unidade: FCFRP
Assuntos: ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry, v. 17, n. 1, p. 48-56, 2017Tradução . . Disponível em: https://doi.org/10.2174/1871520616666160526103432. Acesso em: 23 out. 2025.
APA
Eloy, J. O., Petrilli, R., Brueggemeier, R. W., Marchetti, J. M., & Lee, R. J. (2017). Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry, 17( 1), 48-56. doi:10.2174/1871520616666160526103432
NLM
Eloy JO, Petrilli R, Brueggemeier RW, Marchetti JM, Lee RJ. Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 1): 48-56.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/1871520616666160526103432
Vancouver
Eloy JO, Petrilli R, Brueggemeier RW, Marchetti JM, Lee RJ. Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 1): 48-56.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/1871520616666160526103432
Artigo de periodico
Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells (2017)
Petrilli, Raquel; Eloy, Josimar O.; Lopez, Renata Fonseca Vianna; Lee, Robert J.
Fonte: Anti-Cancer Agents in Medicinal Chemistry. Unidade: FCFRP
Assuntos: ANTINEOPLÁSICOS, NEOPLASIAS CUTÂNEAS, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRILLI, Raquel et al. Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells. Anti-Cancer Agents in Medicinal Chemistry, v. 17, n. 2, p. 301-308, 2017Tradução . . Disponível em: https://doi.org/10.2174/1871520616666160526110913. Acesso em: 23 out. 2025.
APA
Petrilli, R., Eloy, J. O., Lopez, R. F. V., & Lee, R. J. (2017). Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells. Anti-Cancer Agents in Medicinal Chemistry, 17( 2), 301-308. doi:10.2174/1871520616666160526110913
NLM
Petrilli R, Eloy JO, Lopez RFV, Lee RJ. Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 2): 301-308.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/1871520616666160526110913
Vancouver
Petrilli R, Eloy JO, Lopez RFV, Lee RJ. Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 2): 301-308.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/1871520616666160526110913
Artigo de periodico
Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy (2016)
Eloy, Josimar O.; Petrilli, Raquel; Topan, José Fernando; Antonio, Heriton Marcelo Ribeiro; Barcellos, Juliana Palma Abriata; Chesca, Deise Lúcia; Serafini, Luciano Neder; Tiezzi, Daniel Guimarães; Lee, Robert J.; Marchetti, Juliana Maldonado
Fonte: Colloids and Surfaces B: Biointerfaces. Unidades: FMRP, FCFRP
Assuntos: NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids and Surfaces B: Biointerfaces, v. 141, p. 74-82, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2016.01.032. Acesso em: 23 out. 2025.
APA
Eloy, J. O., Petrilli, R., Topan, J. F., Antonio, H. M. R., Barcellos, J. P. A., Chesca, D. L., et al. (2016). Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids and Surfaces B: Biointerfaces, 141, 74-82. doi:10.1016/j.colsurfb.2016.01.032
NLM
Eloy JO, Petrilli R, Topan JF, Antonio HMR, Barcellos JPA, Chesca DL, Serafini LN, Tiezzi DG, Lee RJ, Marchetti JM. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy [Internet]. Colloids and Surfaces B: Biointerfaces. 2016 ; 141 74-82.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.colsurfb.2016.01.032
Vancouver
Eloy JO, Petrilli R, Topan JF, Antonio HMR, Barcellos JPA, Chesca DL, Serafini LN, Tiezzi DG, Lee RJ, Marchetti JM. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy [Internet]. Colloids and Surfaces B: Biointerfaces. 2016 ; 141 74-82.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.colsurfb.2016.01.032
Artigo de periodico
Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles (2015)
Souza, Marina Claro de; Marotta-Oliveira, Samantha Sant'Anna; Rocha, Nathália Helena Souza; Eloy, Josimar O.; Marchetti, Juliana Maldonado
Fonte: Journal of Liquid Chromatography and Related Technologies. Unidade: FCFRP
Assuntos: NEOPLASIAS MAMÁRIAS, ESTRÓGENOS, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marina Claro de et al. Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles. Journal of Liquid Chromatography and Related Technologies, v. 38, n. 12, p. 1223-1229, 2015Tradução . . Disponível em: https://doi.org/10.1080/10826076.2015.1032418. Acesso em: 23 out. 2025.
APA
Souza, M. C. de, Marotta-Oliveira, S. S. 'A., Rocha, N. H. S., Eloy, J. O., & Marchetti, J. M. (2015). Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles. Journal of Liquid Chromatography and Related Technologies, 38( 12), 1223-1229. doi:10.1080/10826076.2015.1032418
NLM
Souza MC de, Marotta-Oliveira SS'A, Rocha NHS, Eloy JO, Marchetti JM. Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles [Internet]. Journal of Liquid Chromatography and Related Technologies. 2015 ; 38( 12): 1223-1229.[citado 2025 out. 23 ] Available from: https://doi.org/10.1080/10826076.2015.1032418
Vancouver
Souza MC de, Marotta-Oliveira SS'A, Rocha NHS, Eloy JO, Marchetti JM. Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles [Internet]. Journal of Liquid Chromatography and Related Technologies. 2015 ; 38( 12): 1223-1229.[citado 2025 out. 23 ] Available from: https://doi.org/10.1080/10826076.2015.1032418

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Título da fonte

Indexado em